
BIOLOGICAL TESTING PRODUCTS COMPANY LMNX BECOMES A BUYOUT TARGET
Luminex Corporation (LMNX) has become a buyout target. There is an 80% probability of a deal ultimately happening. LMNX is trading at $32.09 as of this writing. The most likely acceptable bid is in the zone of $38 to $42. If a bidding war erupts, the stock can go higher.







